Skip to main content
Log in

Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. World Health Organization Weekly epidemiological record, 8 September 2017; 92(36):521–536

  2. Sack DA, Sack RB, Chaignat CL (2006) Getting serious about cholera. N Engl J Med 355(7):649–651

    Article  CAS  PubMed  Google Scholar 

  3. Livermore DM, Tulkens PM (2009) Temocillin revived. J Antimicrob Chemother 63(2):243–245

    Article  CAS  PubMed  Google Scholar 

  4. De Jongh R, Hens R, Basma V, Mouton J, Tulkens P, Carryn S (2008) Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 61(2):382–388

    Article  CAS  PubMed  Google Scholar 

  5. Bier N, Schwartz K, Guerra B, Strauch E (2015) Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Front Microbiol 6:1179

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dengo-Baloi LC, Sema-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP (2017) Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PLoS One 12 (8):e0181496

Download references

Funding

This investigation was funded by Belpharma S.A., Luxembourg.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastien Van de Velde.

Ethics declarations

Conflict of interest

MR and MM have received sponsorship from Belpharma to attend scientific meetings. SVDV is an employee of Eumedica s.a. RS and MRF declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahbar, M., Saboorian, R., Van de Velde, S. et al. Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran. Eur J Clin Microbiol Infect Dis 38, 615–616 (2019). https://doi.org/10.1007/s10096-019-03483-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-019-03483-5

Navigation